Molina Healthcare (NYSE:MOH - Get Free Report) updated its FY 2025 earnings guidance on Monday. The company provided EPS guidance of 21.500-22.500 for the period, compared to the consensus EPS estimate of 24.480. The company issued revenue guidance of -. Molina Healthcare also updated its Q2 2025 guidance to 5.500-5.500 EPS.
Analyst Upgrades and Downgrades
Several research firms have commented on MOH. Morgan Stanley downgraded shares of Molina Healthcare from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $364.00 to $266.00 in a research note on Thursday. Baird R W downgraded shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Truist Financial upped their price objective on shares of Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Guggenheim initiated coverage on shares of Molina Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Finally, Wall Street Zen downgraded shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Eleven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $357.21.
Get Our Latest Analysis on Molina Healthcare
Molina Healthcare Stock Performance
NYSE MOH traded down $9.05 during trading hours on Thursday, hitting $228.17. 1,440,504 shares of the stock were exchanged, compared to its average volume of 714,063. The company has a market cap of $12.37 billion, a price-to-earnings ratio of 11.02, a price-to-earnings-growth ratio of 1.00 and a beta of 0.55. Molina Healthcare has a 12-month low of $227.68 and a 12-month high of $365.23. The stock has a 50-day moving average of $295.21 and a 200 day moving average of $303.75. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.87.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The business had revenue of $11.15 billion for the quarter, compared to analysts' expectations of $10.86 billion. During the same quarter in the prior year, the firm posted $5.73 EPS. The company's revenue was up 12.2% compared to the same quarter last year. As a group, equities research analysts forecast that Molina Healthcare will post 24.4 earnings per share for the current year.
Insider Activity at Molina Healthcare
In other Molina Healthcare news, Director Richard M. Schapiro sold 669 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the sale, the director directly owned 11,244 shares of the company's stock, valued at approximately $3,603,702. The trade was a 5.62% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of Molina Healthcare stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the transaction, the chief executive officer owned 257,715 shares in the company, valued at $82,484,262.90. The trade was a 25.35% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Molina Healthcare
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Focus Partners Wealth increased its position in shares of Molina Healthcare by 82.7% in the 1st quarter. Focus Partners Wealth now owns 3,749 shares of the company's stock worth $1,235,000 after purchasing an additional 1,697 shares during the last quarter. Woodline Partners LP bought a new stake in shares of Molina Healthcare during the 1st quarter valued at about $1,541,000. Goldman Sachs Group Inc. grew its position in shares of Molina Healthcare by 19.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company's stock valued at $82,172,000 after buying an additional 40,531 shares during the last quarter. Jones Financial Companies Lllp grew its position in shares of Molina Healthcare by 713.3% during the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company's stock valued at $544,000 after buying an additional 1,448 shares during the last quarter. Finally, NewEdge Advisors LLC grew its position in shares of Molina Healthcare by 33.4% during the 1st quarter. NewEdge Advisors LLC now owns 1,106 shares of the company's stock valued at $364,000 after buying an additional 277 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.
Molina Healthcare Company Profile
(
Get Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Recommended Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.